The Intellectual Property & Science business of Thomson Reuters,today released The World in 2025: 10 Predictions of Innovation, a new report that predicts the landscape of science and technology in 2025 by mining global patent data and scientific literature.
To conduct the study, researchers identified the top 10 emerging scientific research fronts based on an analysis of citation rankings using Thomson Reuters Web of Science. They next looked at global patent data in the Derwent World Patents Index to identify the top 10 patent fields with the highest number of inventions containing a priority date of 2012 and beyond. The resulting technology areas with the highest level of commercial and scientific research interest were then reviewed to identify hot spots of innovation that will lead to tomorrow’s biggest breakthroughs.
The study predicts that advancements in ribonucleic acid-guided (RNA-guided) engineering will advance to a point where it will be possible to create a human genome engineering platform for identifying and treating disease-causing agents in humans and hence Type I diabetes will be preventable in the future. This field currently leads all areas of genetic-engineering patenting and has been identified as an emerging research front in the scientific literature.
It also says that DNA Mapping at Birth will be the norm. Analysis of the human genome continues to be one of the hottest areas of scientific research, with one recent paper collecting over 1,000 citations. Advancements in nanotechnology coupled with more widespread Big Data technologies make in vivo measurements, for diagnoses to conduct precise, cell-level screenings, possible.
Additional predictions include: Cancer treatments have very few toxic side effects and dementia declines. “While we do not purport to own a crystal ball, we do have the next best thing: citations to scientific literature and patent content. When analyzed in aggregate, these provide a fascinating window into innovations that will change our lives in the future,” said Basil Moftah, president, Thomson Reuters IP & Science. “By analyzing current R&D activity and commercial pipelines, we are shining a spotlight on some of the most exciting developments that will emerge over the next decade.”
- Advertisement -
